Efficacy and safety of fluvastatin in different doses in adults with mixed dyslipidemia or primary hypercholesterolemia
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Fluvastatin (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual patient number is 325 according to ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (April 2006) added as reported by ClinicalTrials.gov.
- 25 Sep 2006 Status change